研究进展关于脂肪细胞外体在癌症进展中的作用
Yun Wang1, Xiaojiang Li2, Dalong Liu2
1Department of Breast and Thyroid Surgery, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, 130021, China.
Oncology research
|September 23, 2024
概括
外体,小小的囊泡参与细胞通信,显著影响癌症的发展和进展. 了解它们的作用是开发新的癌症诊断和治疗方法的关键.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 细胞外囊泡 细胞外囊泡
背景情况:
- 外体是细胞间通信的关键媒介,由各种细胞类型释放出来.
- 它们在癌症发展,进展和治疗耐药性方面的作用越来越被认可.
- 外基因组影响受体细胞的过程,包括 stromal 重编程,免疫反应和转移.
研究的目的:
- 提供对外体组件及其在瘤发生中的作用的全面审查.
- 阐明外体对癌症生长,进展和治疗反应的影响.
- 突出外体的潜力作为诊断指标和瘤学的治疗目标.
主要方法:
- 文献综述和综合关于癌症外体的当前研究.
- 对外体载荷及其对受体细胞的功能影响的分析.
- 探索癌症发育和治疗耐药性的外体介导机制.
主要成果:
- 外体提供生物活性分子,改变本地和遥远的微环境.
- 外基因组介导的沟通会影响癌细胞的激活,扩张和转移.
- 外体有助于获得对癌症疗法的耐药性.
结论:
- 外体在癌症的各个阶段都发挥着多方面的作用,从发病到转移.
- 向外体路径为新型癌症疗法提供了有前途的途径.
- 外基因组作为癌症诊断和预后的生物标志物具有重大潜力.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


